{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:25:18Z","timestamp":1769279118353,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.intimp.2011.11.014","type":"journal-article","created":{"date-parts":[[2011,12,11]],"date-time":"2011-12-11T01:51:57Z","timestamp":1323568317000},"page":"217-225","source":"Crossref","is-referenced-by-count":10,"title":["Fluticasone propionate and Salmeterol combination induces SOCS-3 expression in airway epithelial cells"],"prefix":"10.1016","volume":"12","author":[{"given":"Najmunnisa","family":"Nasreen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazli","family":"Khodayari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagyalaxmi","family":"Sukka-Ganesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriram","family":"Peruvemba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2011.11.014_bb0005","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(03)14416-9","article-title":"Chronic obstructive pulmonary disease","volume":"362","author":"Calverley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2011.11.014_bb0010","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0091-6749(03)02011-6","article-title":"Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma","volume":"112","author":"Sutherland","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0015","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary","volume":"163","author":"Pauwels","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2011.11.014_bb0020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1183\/09031936.02.00301302","article-title":"Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice","volume":"20","author":"Soriano","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.intimp.2011.11.014_bb0025","first-page":"115","article-title":"Budesonide\u2013formoterol (inhalation powder) in the treatment of COPD","volume":"1","author":"Ceylan","year":"2006","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.intimp.2011.11.014_bb0030","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.2112055","article-title":"Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease","volume":"166","author":"Mahler","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2011.11.014_bb0035","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.200508-1321OC","article-title":"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease","volume":"173","author":"Barnes","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2011.11.014_bb0040","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0091-6749(92)90223-O","article-title":"Expression of the potent inflammatory cytokines, granulocyte\u2013macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma","volume":"89","author":"Marini","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1182\/blood.V79.1.45.45","article-title":"Glucocorticoids downregulate gene expression of GM-CSF, NAP-1\/IL-8, and IL-6, but not of M-CSF in human fibroblasts","volume":"79","author":"Tobler","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2011.11.014_bb0050","first-page":"441","article-title":"Fluticasone propionate reduced the production of GM-CSF, IL-6 and IL-8 generated from cultured nasal epithelial cells","volume":"43","author":"Ohnishi","year":"1994","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2011.11.014_bb0055","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/sj.bjp.0703866","article-title":"Beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells","volume":"132","author":"Hallsworth","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0060","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1038\/onc.2008.274","article-title":"MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death","volume":"27","author":"Schickel","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2011.11.014_bb0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1476-5381.1993.tb13855.x","article-title":"Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung","volume":"110","author":"Whelan","year":"1993","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0070","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1164\/rccm.200203-191OC","article-title":"Effect of combining salmeterol and fluticasone on the progression of airway remodeling","volume":"166","author":"Vanacker","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2011.11.014_bb0075","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.rmed.2006.03.001","article-title":"EXCEL: A randomised trial comparing salmeterol\/fluticasone propionate and formoterol\/budesonide combinations in adults with persistent asthma","volume":"100","author":"Dahl","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.intimp.2011.11.014_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1165\/ajrcmb.23.1.3985","article-title":"Synergistic inhibition by beta(2)-agonists and corticosteroids on tumor necrosis factor-alpha-induced interleukin-8 release from cultured human airway smooth-muscle cells","volume":"23","author":"Pang","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.immunol.16.1.293","article-title":"Jaks and STATs: biological implications","volume":"16","author":"Leonard","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0090","doi-asserted-by":"crossref","first-page":"12999","DOI":"10.1074\/jbc.271.22.12999","article-title":"Differential activation of acute phase response factor\/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation","volume":"271","author":"Hemmann","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.intimp.2011.11.014_bb0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-5793(99)01662-2","article-title":"LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophages","volume":"463","author":"Bode","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.intimp.2011.11.014_bb0100","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signalling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2011.11.014_bb0105","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.4049\/jimmunol.166.12.7082","article-title":"Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs","volume":"166","author":"Dalpke","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1042\/0264-6021:3530223","article-title":"Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3)","volume":"353","author":"Magrangeas","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.intimp.2011.11.014_bb0115","first-page":"1","article-title":"IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3","author":"Croker","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0120","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.4049\/jimmunol.1003221","article-title":"CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF-alpha and IL-6 and promote cigarette smoke-induced emphysema","volume":"186","author":"Xiong","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0125","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1183\/09031936.03.00040703","article-title":"Chronic obstructive pulmonary disease: molecular and cellular mechanisms","volume":"22","author":"Barnes","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.intimp.2011.11.014_bb0130","first-page":"90","article-title":"Do chronic inhaled steroids alone or in combination with a bronchodilator prolong life in chronic obstructive pulmonary disease patients?","volume":"13","author":"Sin","year":"2007","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.intimp.2011.11.014_bb0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2466-6-3","article-title":"Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978]","volume":"6","author":"Sin","year":"2006","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.intimp.2011.11.014_bb0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","article-title":"Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial","volume":"361","author":"Calverley","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.intimp.2011.11.014_bb0145","doi-asserted-by":"crossref","first-page":"L559","DOI":"10.1152\/ajplung.00075.2006","article-title":"Cyclical stretch induces PlGF expression in bronchial epithelial cells via nitric oxide release","volume":"292","author":"Mohammed","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/01902140802406059","article-title":"Nuclear localization of active matrix metalloproteinase-2 in cigarette smoke-exposed apoptotic endothelial cells","volume":"35","author":"Aldonyte","year":"2009","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.intimp.2011.11.014_bb0155","doi-asserted-by":"crossref","first-page":"L115","DOI":"10.1152\/ajplung.90587.2008","article-title":"Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro","volume":"297","author":"Nasreen","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0160","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/ni1012","article-title":"Suppressors of cytokine signaling and immunity","volume":"4","author":"Kubo","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1084\/jem.20020939","article-title":"A role of suppressor of cytokine signaling 3 (SOCS3\/CIS3\/SSI3) in CD28-mediated interleukin 2 production","volume":"197","author":"Matsumoto","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2011.11.014_bb0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1165\/ajrcmb.20.4.3265","article-title":"Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids","volume":"20","author":"Atsuta","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0175","first-page":"388","article-title":"Comparison of the effects of two long-acting beta2-agonists on cytokine secretion by human airway epithelial cells","volume":"40","author":"Chiu","year":"2007","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.intimp.2011.11.014_bb0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2005.05.003","article-title":"Molecular mechanisms and cellular effects of glucocorticosteroids","volume":"25","author":"Barnes","year":"2005","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.intimp.2011.11.014_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2005.02.006","article-title":"Serum surfactant protein D is increased in acute and chronic inflammation in mice","volume":"31","author":"Fujita","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2011.11.014_bb0190","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1164\/rccm.200408-1041OC","article-title":"Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy","volume":"172","author":"Usmani","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.intimp.2011.11.014_bb0195","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1183\/09031936.03.00031803","article-title":"Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-beta kinase pathway","volume":"21","author":"Escotte","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.intimp.2011.11.014_bb0200","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1476-5381.1991.tb12487.x","article-title":"Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung","volume":"104","author":"Butchers","year":"1991","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0205","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0091-6749(97)70280-X","article-title":"Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells","volume":"100","author":"Bissonnette","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0210","first-page":"12","article-title":"Influence of salmeterol, a long-acting beta 2-adrenoceptor agonist, on IgE-mediated histamine release from human basophils","volume":"4","author":"Kleine-Tebbe","year":"1994","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1399-3003.1999.14b07.x","article-title":"The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma","volume":"14","author":"Roberts","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.intimp.2011.11.014_bb0220","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.4049\/jimmunol.172.11.6969","article-title":"Suppressors of cytokine signaling regulate Fc receptor signaling and cell activation during immune renal injury","volume":"172","author":"Gomez-Guerrero","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0225","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1172\/JCI13568","article-title":"Induction of the cytokine signal regulator SOCS3\/CIS3 as a therapeutic strategy for treating inflammatory arthritis","volume":"108","author":"Shouda","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2011.11.014_bb0230","doi-asserted-by":"crossref","unstructured":"Raghavendra Rao VL, Bowen KK, Dhodda VK, Song G, Franklin JL, Gavva NR, et al. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. Journal of neurochemistry 2002;83:1072\u201386.","DOI":"10.1046\/j.1471-4159.2002.01208.x"},{"key":"10.1016\/j.intimp.2011.11.014_bb0235","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0092-8674(00)80049-5","article-title":"SOCS3 is essential in the regulation of fetal liver erythropoiesis","volume":"98","author":"Marine","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2011.11.014_bb0240","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI13939","article-title":"Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways","volume":"108","author":"Yasukawa","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.intimp.2011.11.014_bb0300","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2005.02.048","article-title":"Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo","volume":"43","author":"Yang","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2011.11.014_bb0305","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.4049\/jimmunol.167.9.5329","article-title":"Novel anti-inflammatory effects of the inhaled corticosteroid fluticasone propionate during lung myofibroblastic differentiation","volume":"167","author":"Cazes","year":"2001","journal-title":"J Immunol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576911004541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576911004541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T16:07:33Z","timestamp":1593360453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576911004541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1567576911004541"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2011.11.014","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}